Mundth et al., 1971 - Google Patents
Myocardial revascularization for the treatment of cardiogenic shock complicating acute myocardial infarctionMundth et al., 1971
- Document ID
- 13959727167570724010
- Author
- Mundth E
- Buckley M
- Leinbach R
- DeSanctis R
- Sanders C
- Kantrowitz A
- Austen W
- Publication year
- Publication venue
- Surgery
External Links
Snippet
Seven patients with refractory left ventricular power failure and cardiogenic shock complicating acute myocardial infarction have been treated by combining intra-aortic balloon-pump assistance, coronary angiography, and emergency direct coronary arterial …
- 206010007625 Cardiogenic shock 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/10—Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
- A61M1/1037—Pumps having flexible elements, e.g. with membranes, diaphragms, or bladder pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/10—Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps
- A61M1/12—Blood pumps; Artificial hearts; Devices for mechanical circulatory assistance, e.g. intra-aortic balloon pumps implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mundth et al. | Myocardial revascularization for the treatment of cardiogenic shock complicating acute myocardial infarction | |
Isselbacher et al. | Cardiac tamponade complicating proximal aortic dissection. Is pericardiocentesis harmful? | |
Culliford et al. | Aortic valve replacement for aortic stenosis in persons aged 80 years and over | |
Johnson et al. | Treatment of cardiogenic shock in myocardial infarction by intraaortic balloon counterpulsation and surgery | |
Cimochowski et al. | Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support | |
Hochberg et al. | Timing of coronary revascularization after acute myocardial infarction: early and late results in patients revascularized within seven weeks | |
Elliott et al. | Isoproterenol in treatment of heart disease: Hemodynamic effects in circulatory failure | |
Johnson et al. | Coronary artery surgery in diabetics: 261 consecutive patients followed four to seven years | |
Croke et al. | Reversal of advanced left ventricular dysfunction following aortic valve replacement for aortic stenosis | |
O'Rourke et al. | Arterial counterpulsation in severe refractory heart failure complicating acute myocardial infarction. | |
Hochreiter et al. | Myocardial free-wall rupture after acute infarction: survival aided by percutaneous intraaortic balloon counterpulsation. | |
Beyersdorf et al. | Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion | |
MUNDTH | Rupture of the heart complicating myocardial infarction | |
Meyns et al. | Mechanical support with microaxial blood pumps for postcardiotomy left ventricular failure: can outcome be predicted? | |
Mehta et al. | Medical-surgical aspects of left main coronary artery disease | |
FOSTER et al. | Mechanical circulatory assistance with intra-aortic balloon counterpulsation for major abdominal surgery | |
Marchant et al. | Report: Association of coronary artery disease and valvular heart disease in chile | |
Resnekov | Cardiogenic shock | |
Bolooki et al. | Myocardial revascularization after acute myocardial infarction | |
Kafrouni et al. | Single right coronary artery: clinical and angiographic findings with surgical management | |
Eyituoyo et al. | Ventricular fibrillation 7 years after left ventricular assist device implantation | |
Jebara et al. | Coronary artery-left ventricle fistulas after cardiac surgery | |
Kuchar et al. | Long-term survival after counterpulsation for medically refractory heart failure complicating myocardial infarction and cardiac surgery | |
Cooper Jr et al. | Preoperative intra-aortic balloon assist in high risk revascularization patients | |
BOLOOKI et al. | Clinical, surgical, and pathologic correlation in patients with acute myocardial infarction and pump failure |